Beyond Air Plunges 21.05% on Revenue Miss

On June 18, 2025, Beyond Air's stock price plummeted by 21.05% in pre-market trading, marking a significant decline for the company.

Beyond Air reported its fourth-quarter revenue, totaling $1.15 million, which fell short of market expectations set at $1.39 million. This shortfall resulted in a 16.67% negative surprise, despite the company beating earnings per share (EPS) estimates. The company posted a loss of $0.09 per share for the quarter, which was better than analyst estimates of a $0.15 per share loss.

Despite the quarterly revenue miss, Beyond Air's fiscal year 2025 revenue increased by 220% to $3.7 million, compared to $1.2 million in the previous year. This significant growth was driven by the company's innovative products and strategic initiatives. Beyond Air also announced FDA submissions for LungFit PH, a key development that could potentially boost future revenue.

The company's earnings call highlighted the 220% revenue increase for the fiscal year, indicating strong growth potential. However, the market's reaction to the quarterly revenue miss suggests that investors are focusing on short-term performance rather than long-term growth prospects. The significant pre-market drop in stock price reflects investor concerns about the company's ability to meet revenue expectations in the near term.